Peptide Oral Dissolving Film · B2B
Dietary-Grade Peptide Oral Strips
Compliant ingredient screening, custom flavor, film parameters and private-label packaging.
Content updated · Evidence and updates
The focus and sleep category contains eight distinct concepts, from melatonin combinations to caffeine and B vitamins. They should be assessed separately: a nighttime brief and an alertness brief have different intended users and label requirements. Do not infer a shared dose, onset time or effect from their placement in the same catalog. Ingredient classification may differ between destination markets, so the commercial pathway must be reviewed before artwork or launch commitments. The listed ingredients are starting points for formulation discussion. Film content, taste, stability and suitability for the intended population still need project evidence. A sample should be traceable to a confirmed formula and test plan. These entries provide no treatment recommendation for insomnia, anxiety, cognitive impairment or another medical condition, and they are not consumer-use instructions.

A reference name is a way to identify the discussion, not a substitute for a specification. Request the ingredient identity, proposed content basis, film dimensions, package configuration and required quality records. Population suitability and final claim wording should be reviewed before consumer-facing artwork is approved.
No. The catalog does not provide a confirmed per-strip specification for these entries. Agree the ingredient form, amount, film parameters and analytical basis for each project.
No. The supplied illustration is a concept visual, not a tested product photograph or evidence of safety, efficacy, absorption or availability.
Source: Hytan Product Catalog 2026, Category C, beginning on page 15. Supplier-provided reference material reviewed for this web integration on October 27, 2026. This attribution is not independent product verification.